Now trading at a price of $12.72, Elanco Animal Health has moved 0.1% so far today.
Over the last year, Elanco Animal Health logged a -2.8% change, with its stock price reaching a high of $14.69 and a low of $7.88. Over the same period, the stock underperformed the S&P 500 index by -17.8%. As of April 2023, the company's 50-day average price was $10.58. Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. Based in Greenfield, IN, the mid-cap Health Care company has 9,000 full time employees. Elanco Animal Health has not offered a dividend during the last year.
Increasing Revenues but Narrowing Margins:
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Revenue (MM) | $3,067 | $3,071 | $3,271 | $4,764 | $4,411 | $4,411 |
| Revenue Growth | n/a | 0.14% | 6.51% | 45.64% | -7.41% | 0.0% |
| Operating Margins | 4% | 3% | -21% | -12% | -2% | -26% |
| Net Margins | 3% | 2% | -18% | -10% | -2% | -26% |
| Net Income (MM) | $86 | $68 | -$574 | -$483 | -$78 | -$1,144 |
| Net Interest Expense (MM) | $30 | $79 | $178 | $236 | $241 | $272 |
| Depreciation & Amort. (MM) | $296 | $314 | $517 | $716 | $682 | $691 |
| Earnings Per Share | $0.28 | $0.18 | -$1.3 | -$0.99 | -$0.16 | -$2.3200000000000003 |
| Free Cash Flow (MM) | $353 | $84 | -$160 | $357 | $315 | -$11 |
| Capital Expenditures (MM) | $134 | $140 | $119 | $126 | $137 | $138 |
| Current Ratio | 2.58 | 2.9 | 1.65 | 1.99 | 1.93 | 2.82 |
| Total Debt (MM) | $2,608 | $2,355 | $6,127 | $6,319 | $5,836 | $5,909 |
Elanco Animal Health has consistently negative margins with a negative growth trend, declining EPS growth, and irregular cash flows. On the other hand, the company has growing revenues and a flat capital expenditure trend working in its favor. Furthermore, Elanco Animal Health has an average amount of debt.
Elanco Animal Health does not have a meaningful trailing P/E ratio since its earnings per share are currently in the red. Based on its EPS guidance of $0.89, the company has a forward P/E ratio of 11.9. In comparison, the average P/E ratio for the Health Care sector is 30.21. On the other hand, the market is undervaluing Elanco Animal Health in terms of its equity because its P/B ratio is 1.02. In comparison, the sector average is 4.08.
There's an Analyst Consensus of Some Upside Potential for Elanco Animal Health:
The 8 analysts following Elanco Animal Health have set target prices ranging from $10.0 to $18.0 per share, for an average of $13.75 with a hold rating. As of April 2023, the company is trading -23.1% away from its average target price, indicating that there is an analyst consensus of some upside potential.
Elanco Animal Health has an average amount of shares sold short because 3.6% of the company's shares are sold short. Institutions own 101.4% of the company's shares, and the insider ownership rate stands at 0.57%, suggesting a small amount of insider investors. The largest shareholder is Dodge & Cox Inc, whose 17% stake in the company is worth $1,071,487,024.
